HPC is an aneurysm implant and Flow Diverter coating, which shall reduce the risk of thrombosis on the surface of stents. Due to the thrombogenic surface, platelet function-inhibiting drugs are …

Since its founding in 2005, phenox has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases.

Products and associated components are not available in all countries or regions. Please contact your phenox representative for details regarding product availability.

Bochum, 21. April 2022 – Wallaby Medical („Wallaby“) hat heute mitgeteilt, dass man die phenox GmbH einschließlich des Tochterunternehmens femtos GmbH (gemeinsam „phenox“) …

2022年4月21日 · The broadened product portfolio, enhanced R&D capability and expanded geographic coverage will provide Wallaby-phenox with an unparalleled competitive edge as …

Products and associated components are not available in all countries or regions. Please contact your phenox representative for details regarding product availability.

Do you want to find out more about phenox as an employer? Do you also share a passion for medical devices and technology? Then explore more information why phenox is the best place …

Founded in 2005, phenox is a privately held company that develops and manufactures innovative treatment options for both hemorrhagic and acute ischemic stroke. phenox has operations in …

Products and associated components are not available in all countries or regions. Please contact your phenox representative for details regarding product availability.

HPC prevents the triggering of the clotting cascade and reduces the risk of thrombus formation on phenox neurovascular implants ; HPC mimics the glycocalix, thus the platelets do not …